Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Drucker DJ, Buse JB, Taylor K et al (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Furthermore, it is important to note that these compounds may have deviations from the brand name counterpart
for managing type 2 diabetes and supporting weight loss
These medications are metabolised and eliminated through different pathways, reducing the likelihood of direct drug-drug interactions
Licensed indications for the use of alternative GLP-1 RAs or the dual GIP/GLP-1 RA tirzepatide
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
